True North Contract Research

The final phase of clinical testing is where the rubber really hits the road. Phase III trials enroll large patient populations to confirm a new treatment's safety and efficacy on a broader scale, often as it compares to the current standard treatment. As an ophthalmology-focused CRO, we excel at navigating the complexities of these large-scale studies. Our experienced team supports sponsors every step of the way, from regulatory strategy to robust trial monitoring. We're passionate about bringing innovative ophthalmic therapies to those who need them most.  https://truenorthcro.com/ #ClinicalTrials #PhaseThreeTrial #TrueNorthResearch #FDAApproval #RegulatoryStrategy True North Contract Research Keeley Puls-Boever Travis Holman, MS

What a groundbreaking year for ophthalmology! Thank you Ophthalmology Breaking News for this recap covering gene therapy to new devices. We look forward to seeing how these advances will reshape treatment possibilities in 2025. True North Contract Research is proud to champion the researchers and innovators who make these discoveries possible. #innovation #ophthalmology #2025 #yearahead https://lnkd.in/dpH4rgch

Once a new ophthalmic treatment has demonstrated initial safety, Phase II trials dive deeper. These medium-sized studies continue to assess the therapy's safety and efficacy, while refining the optimal dosage. As an ophthalmology CRO, we leverage our specialized expertise to design these trials, monitor progress, and analyze the results. Our goal is to efficiently generate the data sponsors need to advance their innovations. #ClinicalTrials #PhaseTwoTrial #TrueNorthResearch #Ophthalmology  True North Contract Research Keeley Puls-Boever Travis Holman, MS

As an ophthalmology-focused CRO, we know the importance of thoroughly testing new treatments to ensure patient safety. That's why Phase I clinical trials are a critical first step. These small-scale studies determine a safe dose range and evaluate the safety and tolerability of an investigational therapy in healthy volunteers or those with the target condition. It's all about laying the groundwork for further development. We're proud to support sponsors through this vital phase.  https://truenorthcro.com/ #ClinicalTrials #PhaseOneTrial #TrueNorthResearch #ClinicalResearch   True North Contract Research Keeley Puls-Boever Travis Holman

On this momentous day, we celebrate 75 years since Sir Harold Ridley revolutionized ophthalmology by creating the first intraocular lens (IOL) in 1949. What began as a groundbreaking solution for cataract patients has evolved into a sophisticated technology that restores and enhances vision for millions worldwide. From those early acrylic lenses to today's advanced multifocal and adaptive designs, the IOL represents the remarkable spirit of medical innovation that drives our work in clinical research. We honor Ridley's vision and the countless researchers and clinicians who continue to push the boundaries of ophthalmic care. #Ophthalmology #FirstIOL #Catracts #ClinicalResearch

True North thanks its community of researchers, data scientists, and sponsors dedicated to advancing breakthrough treatments in the field of ophthalmology. We all have a shared vision of a future where sight is preserved, restored, and accessible. Thank you for your commitment to improving sight and lives through research.    #Gratitudepost #Ophthalmology #VisionResearch #Gratitude #ClinicalResearch   True North Contract Research Keeley Puls-Boever Travis Holman  

Glaucoma can progress without noticeable symptoms in its early stages. It is a complex eye condition that typically results from increased pressure inside the eye, known as intraocular pressure, which can gradually damage the optic nerve. As a clinical research organization dedicated to advancing safe and effective new glaucoma treatments, True North is on a mission to help patients preserve their sight by supporting sponsors in bringing their breakthrough technologies to market. Click like to spread awareness and support Glaucoma research.    #GlaucomaAwareness #EyeHealth #TrueNorthResearch #ProtectYourSight #EarlyIntervention  True North Contract Research Keeley Puls-Boever Travis Holman

Rigorous trial monitoring is essential for generating high-quality data and keeping clinical studies on track. At True North, our dedicated team of ophthalmology experts leverages the latest technologies and processes to provide comprehensive oversight of your trials. From site management to safety monitoring to data analysis, we've got you covered every step of the way.  #ClinicalTrialMonitoring #DataQuality #TrueNorthResearch #Ophthalmology True North Contract Research Keeley Puls-Boever Travis Holman

According to the World Health Organization (WHO), Glaucoma is the leading irreversible cause of blindness in the world. True North supports innovators working on breakthrough treatments to slow the progression of glaucoma. With early detection and ongoing research, glaucoma can be managed. Regular eye exams, particularly for those over 40 or with a family history of glaucoma, are vital to catching this condition early.    Give yourself the gift of an eye exam.  #GlaucomaAwareness #EyeHealth #TrueNorthResearch #ProtectYourSight True North Contract Research Keeley Puls-Boever Travis Holman  

In case you missed it, The FDA released new guidance on Conducting Clinical Trials With Decentralized Elements. This includes information to make clinical trials more accessible and efficient. Decentralized elements include telehealth visits, in-home visits by remote personnel, or local healthcare provider interactions. Read Guidance at the link below. https://lnkd.in/exDQdykh #ClinicalTrials #DecentralizedTrials #FDA #Telehealth #TrueNorthResearch FDA True North Contract Research Keeley Puls-Boever Travis Holman